Allotypes associated with B apolipoproteins in rabbits

Area of Science:

• Immunogenetics
• Lipid Metabolism
• Biochemistry

Background:

• Apolipoprotein B (apoB) is the primary protein component of atherogenic lipoproteins.
• Lipoprotein allotypes are genetic variants of apolipoproteins that can influence lipid metabolism and disease risk.
• Rabbit linkage group VIII harbors genes encoding apolipoprotein B allotypes (Lpq).

Purpose of the Study:

• To characterize the apolipoprotein targets of rabbit alloantisera (anti-Lpq1, anti-Lpq2, anti-Lpq3, anti-Lpq4).
• To determine the distribution of these apolipoprotein B allotypes across various lipoprotein fractions.
• To investigate potential differences in allotype distribution that may relate to lipoprotein metabolism.

Main Methods:

• Western blot analysis using specific alloantisera and anti-apoB antiserum.
• Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to assess molecular weights.
• Quantitative competitive Enzyme-Linked Immunosorbent Assay (ELISA) to measure allotype concentrations in lipoprotein fractions.

Main Results:

• Alloantisera strongly reacted with apolipoproteins of 320,000 and 220,000 molecular weights, identified as apolipoprotein B.
• Lpq1, Lpq2, and Lpq4 allotypes were most concentrated in very low-density (VLDL), intermediate-density (IDL), and low-density (LDL) lipoproteins, with lower levels in chylomicrons and high-density lipoproteins (HDL).
• Lpq3 allotype showed highest concentrations in IDL and LDL, with significantly lower levels in VLDL and chylomicrons, but notably higher concentrations in HDL (20% of LDL levels) compared to other allotypes.

Conclusions:

• The studied alloantisera recognize allotypes associated with rabbit apolipoprotein B.
• Distinct distributional patterns of Lpq allotypes among lipoprotein classes suggest differential roles or processing.
• The unique distribution of Lpq3 in HDL warrants further investigation into its potential functional significance.